...
首页> 外文期刊>Journal of Chemistry >Synthesis and Crystalline Structure of Zinc Complexes with Antihypertensive Drug Lisinopril
【24h】

Synthesis and Crystalline Structure of Zinc Complexes with Antihypertensive Drug Lisinopril

机译:降压药利诺普利锌配合物的合成及晶体结构

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The structural investigation of Zn2+ complexes with the ligand lisinopril (LIS), an inhibitor of angiotensin-converting enzyme (ACE), was performed. The main objective is to compare if Zn-LIS coordination in vitro is similar to that observed in vivo. Two zinc complexes were obtained from different synthetic routes. The synthesis of LISZn1 used stirring, while for LISZn2 involved solvothermal conditions, which favoured the full deprotonation of lisinopril ligand. In this sense, the different synthetic routes resulted in the formation of complexes with notorious chemical and structural differences. The crystal structure of LISZn2 showed that the ligand is coordinated to Zn2+ ion by oxygen and nitrogen atoms which is different from that observed in vivo. In vitro, the coordination of lisinopril occurs only by an oxygen atom of the central carboxylate group. LISZn2 forms a one-dimensional (1D) coordination polymer and presents disorder atoms in its unit cell.
机译:进行了Zn2 +与配体赖诺普利(LIS)(血管紧张素转化酶(ACE)的抑制剂)的复合物的结构研究。主要目的是比较体外Zn-LIS配位是否类似于体内观察到的配位。从不同的合成途径获得了两种锌络合物。 LISZn1的合成使用搅拌,而对于LISZn2则涉及溶剂热条件,这有利于赖诺普利配体的完全去质子化。从这个意义上说,不同的合成途径导致形成了臭名昭著的化学和结构差异的复合物。 LISZn2的晶体结构表明该配体通过氧和氮原子与Zn2 +离子配位,这与体内观察到的不同。在体外,赖诺普利的配位仅通过中央羧酸酯基团的氧原子发生。 LISZn2形成一维(1D)配位聚合物,并在其晶胞中呈现无序原子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号